CDC Advisory Committee Launches Review of COVID-19 Vaccines

The panel is going to study the efforts of repeated booster doses as well as how vaccines and COVID-19 have affected deaths and hospitalizations from any cause.

Retsef Levi speaks during the first meeting of the CDC's Advisory Committee On Immunization Practices at the CDC global headquarters in Atlanta on June 25, 2025. Photo by Elijah Nouvelage/Getty Images

A group that advises the Centers for Disease Control and Prevention (CDC) is going to review various aspects of COVID-19 vaccines, including concerns about the persistence of messenger ribonucleic acid (mRNA), according to a new document.

The Advisory Committee on Immunization Practices (ACIP) work group on COVID-19 vaccines will review data on the shots related to their safety, effectiveness, and immunogenicity, according to the Aug. 20 document, which was released by the CDC.